Acyclo-retinoic acid induces apoptosis in human prostate cancer cells

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 689-695

  Kotake Nara, Eiichi ^a   Kim, Seon Jae ^a   Kobori, Masuko ^a   Miyashita, Kazuo ^a   Nagao, Akihiko ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Acyclo retinoic acid; Apoptosis; Cell viability; Human prostate cancer cells

Indexed keywords

ACYCLORETINOIC ACID; ALITRETINOIN; DNA FRAGMENT; FENRETINIDE; GERANYLGERANOIC ACID; LYCOPENE; RETINOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; HUMANS; MALE; PROSTATIC NEOPLASMS; RETINOIDS; TUMOR CELLS, CULTURED;

EID: 0036254464     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cancer statistics, 2000
2. Intake of carotenoids and retinol in relation to risk of prostate cancer
3. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature
4. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
5. β-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma
6. Lycopene in association with α-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells
7. β-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol
8. Carotenoids affect proliferation of human prostate cancer cells
9. 13-cis-retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cells
10. Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cisretinoic acid
11. N-(4-hydroxyphenyl)retinamide induces cell cycle specific growth inhibition in PC3 cells
12. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells
13. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3
14. Antagonism of androgen action in prostate tumor cells by retinoic acid
15. Effect of retinoic acid on prostatic development
16. Immunohisto-chemical study of the receptors for retinoic acid in prostatic adenocarcinorna
17. The development of biologic end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer
18. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
19. Inhibition of growth and cholesterol synthesis in breast cancer cells by oxidation products of β-carotene
20. Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin
21. Efficacy of all-trans-β-carotene, canthaxanthin, and all-trans-, 9-cis-, and 4-oxoretinoic acids in inducing differentiation of an F9 embryonal carcinoma RAR β-lacZ reporter cell line
22. Formation of cleavage products by autoxidation of lycopene
23. Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 hurnan promyelocytic leukemia cells
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay
25. Identification of programmed cell death in situ via specific labelling DNA fragmentation
26. 1
27. Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cells
28. Retinoid agonist activities of synthetic geranyl geranoic acid derivatives
29. Effect of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells
30. Stimulation of gap junctional communication: Comparison of acyclo-retinoic acid and lycopene
31. Fenretinoide: Induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cells
32. N-(4-hydroxyphenyl)retinamide(4-HPR) decreases neoplastic properties of human prostate cells: An agent for prevention
33. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)
34. Effects of fenretinoide (4-HPR) on prostate LNCaP cell growth, apoptosis and prostate-specific gene expression
35. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells
36. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines
37. Retinoid receptor-dependent and -independent effect of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells
38. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
39. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma
40. 4-Hydroxyphenylretinamide is a highly selective activator of retinoid receptors